WEST PHARMACEUTICAL SERVICES, INC. Expense Breakdown
No Expense Breakdown for WST on this site yet.
- 2026-06-30: Proprietary Products $414.60M; West Vantage $128.50M.
- 2025-06-30: Proprietary Products $371.50M; West Vantage $121.10M.
Source checked: the stored Expense Breakdown page for WST.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Proprietary Products | West Vantage |
|---|
| 2026-06-30 | $414.60M | $128.50M |
|---|
| 2025-06-30 | $371.50M | $121.10M |
|---|
Depreciation, Depletion and Amortization: each quarter (3 month)
| Quarter end | Proprietary Products | West Vantage |
|---|
| 2026-06-30 | $36.30M | $9.20M |
|---|
| 2025-06-30 | $33.70M | $6.80M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Proprietary Products | West Vantage |
|---|
| 2026-06-30 | $19.70M | $0.00 |
|---|
| 2025-06-30 | $19.10M | $0.00 |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Proprietary Products | West Vantage |
|---|
| 2026-06-30 | $69.50M | $8.30M |
|---|
| 2025-06-30 | $61.50M | $7.00M |
|---|